AA Signature provides an innovative approach to treatment planning that focuses on patient outcomes
The International Society of Aesthetic Plastic Surgery reported that non-surgical procedures outnumbered surgical ones globally in 2020
India confronts alarming rates of eye disorders, propelling the urgency of eyecare awareness
Twelve abstracts and two late-breaking presentations demonstrate AbbVie and Allergan Aesthetics' shared commitment to advancing research across a spectrum of dermatologic conditions and aesthetic indications
Diltiazem Hydrochloride Extended-Release Capsules USP are indicated for the treatment of hypertension
Ofloxacin Ophthalmic Solution USP 0.3% is indicated for treatment of eye infections caused during the conditions of conjunctivitis and corneal ulcers
The burden of treating chronic wounds is growing rapidly due to increasing health care costs
Pfizer’s total cumulative revenue from Seagen therapies is expected to reach $36 billion by 2028, according to GlobalData, a leading data and analytics company.
Dr. Fesharaki most recently served as the Chief Scientific Officer and Global Head of R&D for Hikma Pharmaceuticals.
Merzee is a generic equivalent of Taytulla of Allergan Pharmaceuticals International
Subscribe To Our Newsletter & Stay Updated
